Eikon Therapeutics, Inc. Common Stock (EIKN) — Defensive Interval Ratio
Eikon Therapeutics, Inc. Common Stock (EIKN) has a Defensive Interval Ratio of 1533 days as of December 2025. Defensive assets of $231.07 Million (cash $-, short-term investments $231.07 Million, receivables $-) cover 1533 days of daily cash needs of $150.70K/day. See Eikon Therapeutics, Inc. Common Stock (EIKN) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Eikon Therapeutics, Inc. Common Stock Defensive Interval Ratio (2023–2025)
This chart shows how Eikon Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of December 2025, the ratio stands at 1533 days, meaning defensive assets of $231.07 Million can fund 1533 days of operations without new revenue. Also explore Eikon Therapeutics, Inc. Common Stock net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Eikon Therapeutics, Inc. Common Stock (2023–2025)
The table below presents the year-by-year Defensive Interval Ratio for Eikon Therapeutics, Inc. Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see EIKN company net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1533 days | $231.07 Million | $150.70K/day | $- | $231.07 Million | ▲ +945 days |
| 2024 | 588 days | $90.93 Million | $154.65K/day | $- | $90.93 Million | ▼ -3100 days |
| 2023 | 3687 days | $317.63 Million | $86.14K/day | $- | $317.63 Million | — |